āĻšā§āĻŽIPCALAB âĸ NSE
add
IPCA Laboratories Ltd
ā§§,ā§Ģā§Ļā§Ļ.ā§Ļā§Ļâš
⧝ āĻŽāĻžāϰā§āĻ, ā§Ē:ā§Šā§Ģ:ā§Ļ⧍ PM GMT +ā§Ģ:ā§Šā§Ļ · INR · NSE · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§,ā§Ē⧝ā§Ē.⧍ā§Ļâš
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§,ā§Ēā§Ēā§Ž.ā§§ā§Ļâš - ā§§,ā§Ģā§§ā§Ē.⧝ā§Ļâš
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§§,ā§§ā§Ŧā§Ž.⧍ā§Ļâš - ā§§,ā§Ģ⧝ā§Ģ.ā§Ļā§Ļâš
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Š.ā§Žā§§āĻā§ INR
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§.ā§ā§Ē āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
ā§Ēā§§.ā§Žā§¨
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
ā§Ļ.⧍ā§%
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NSE
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
| (INR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ⧍.ā§Šā§¯āĻļāĻ¤Â āĻā§ | ā§Ŧ.ā§Ģā§Ģ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§§.ā§Šā§§āĻļāĻ¤Â āĻā§ | ā§.⧝ā§Ē% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Šā§¨ā§Ŧ.⧍ā§Â āĻā§ | ā§Šā§§.ā§Ē⧝% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§§ā§Š.ā§Ŧā§Ē | ā§¨ā§Š.ā§Ēā§Ē% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ⧧⧍.ā§Ļ⧝ | ā§¨ā§Š.ā§Ŧ⧍% |
EBITDA | ā§Ģā§§ā§Ž.ā§§ā§ŠÂ āĻā§ | ā§§ā§Ģ.ā§ā§Ļ% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§§ā§Ž.ā§Šā§¯% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (INR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§§.⧍ā§ĢāĻļāĻ¤Â āĻā§ | ā§Šā§Ž.⧝ā§Ē% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | â | â |
āĻŽā§āĻ āĻĻāĻžā§ | â | â |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ž.ā§Žā§āĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ⧍ā§Ŧ.ā§¯ā§¯Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ē.ā§Ŧā§Ļ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | â | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ļ.ā§Ē⧝% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
| (INR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Šā§¨ā§Ŧ.⧍ā§Â āĻā§ | ā§Šā§§.ā§Ē⧝% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | â | â |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | â | â |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| â | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧧⧝ āĻ
āĻā§āĻā§, ⧧⧝ā§Ē⧝
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§§ā§Ŧ,ā§ā§ā§Ž